autologous anti-FcRL5 CAR-T cells
Term · Oncology and biomedicine · MLC-T-ONC-011427
A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting Fc receptor-like protein 5 (FcRL5; Fc receptor-homolog 5; FcRH5), with potential antineoplastic activity. Upon administration, autologous anti-FcRL5 CAR-T cells recognize and kill FcRL5-expressing tumor cells. FcRL5, an immune receptor translocation-associated protein/Fc receptor homolog (IRTA/FcRH) family member and a B-cell lineage marker, is overexpressed in multiple myeloma.
| Identifier | MLC-T-ONC-011427 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-FcRL5 CAR-modified T cells; autologous anti-FcRL5 CAR T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011427",
"term": "autologous anti-FcRL5 CAR-T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting Fc receptor-like protein 5 (FcRL5; Fc receptor-homolog 5; FcRH5), with potential antineoplastic activity. Upon administration, autologous anti-FcRL5 CAR-T cells recognize and kill FcRL5-expressing tumor cells. FcRL5, an immune receptor translocation-associated protein/Fc receptor homolog (IRTA/FcRH) family member and a B-cell lineage marker, is overexpressed in multiple myeloma.",
"synonyms": [
"anti-FcRL5 CAR-modified T cells",
"autologous anti-FcRL5 CAR T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-fcrl5-car-t-cells/"
}
Record 2,759 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.